Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15432 |
GSK256073
|
GPR; Others | Endocrinology/Hormones; GPCR/G Protein; Others |
GSK256073 是一种口服有活性的GPR109A 选择性激动剂,也是一种持久的人HCA2激动剂(pEC50:7.5) 。它能够减少脂降解,而显著改善葡萄糖稳态,对 2 型糖尿病和血脂异常具有潜在的研究价值。 | |||
T71180 | Oglufanide disodium | ||
Oglufanide disodium is t he disodium salt of a synthetic form of a naturally-occurring dipeptide consisting of L-glutamic acid and L-tryptophan with potential antiangiogenic and potential immunomodulating activities. Oglufanide inhibits vascular endothelial growth factor (VEGF), which may inhibit angiogenesis. This agent has also been reported to stimulate the immune response to hepatitic C virus and intracellular bacterial infections. Check for active clinical trials or closed clinical trials u... | |||
T71181 | GSK256073 Tris | ||
GSK256073 is an agonist of G-protein coupled receptor 109A (GPR109A). It acts by reducing serum glucose in subjects with type 2 diabetes mellitus. |